Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Budesonide/Formoterol Easyhaler vs Symbicort
NCT03073057Phase 1Completed
- Sponsor
- Orion Corporation
- Start
- Jan 2016
- Primary completion
- Mar 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of budesonide + formoterol in asthma (4 arms), sponsored by Orion Corporation. Primary endpoints: Maximum Plasma Concentration at 24 hours and Area Under the Curve to the last measurable concentration at 24 hours. Started Jan 2016; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03073057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073057.